Individualized Therapies on the Rise: Reflections from the Duke-Margolis/FDA Workshop

Individualized therapies are reshaping drug development. Sabine Ruehle shares insights from the Duke-Margolis/FDA workshop on n-of-1, gene editing, and fit-for-purpose regulation.